2,962
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling

ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 336-347 | Received 07 Dec 2021, Accepted 22 Mar 2022, Published online: 20 Apr 2022

References

  • Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. Ca-a Cancer Journal for Clinicians. 2021;71(1):7–33. doi:10.3322/caac.21654.
  • Pennino FP, Murakami M, Zollo M, Robertson ES. The metastasis suppressor protein NM23-H1 modulates the PI3K-AKT axis through interaction with the p110α catalytic subunit. Oncogenesis. 2021;10(4):34. doi:10.1038/s41389-021-00326-x.
  • Rodriguez-Hernandez I, Maiques O, Kohlhammer L, Cantelli G, Perdrix-Rosell A, Monger J, Fanshawe B, Bridgeman VL, Karagiannis SN, Penin RM, et al. WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion. Nat Commun. 2020;11(1):doi:10.1038/s41467-020-18951-2.
  • Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, et al. Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer. 2008;99(5):734–740. doi:10.1038/sj.bjc.6604482.
  • Volkers L, Mechioukhi Y, Coste B. Piezo channels: from structure to function. Pflugers Archiv-European Journal of Physiology. 2015;467(1):95–99. doi:10.1007/s00424-014-1578-z.
  • Saotome K, Murthy SE, Kefauver JM, Whitwam T, Patapoutian A, Ward AB. Structure of the mechanically activated ion channel Piezol. Nature. 2018;554(7693):481-+. doi:10.1038/nature25453.
  • Gottlieb PA, Sachs F. Piezo1 properties of a cation selective mechanical channel. Channels. 2012;6(4):214–219. doi:10.4161/chan.21050.
  • Li J, Hou B, Beech DJ. Endothelial Piezo1: life depends on it. Channels. 2015;9(1):1–2. doi:10.4161/19336950.2014.986623.
  • Chen X, Wanggou S, Bodalia A, Zhu M, Dong W, Fan JJ, Yin WC, Min H-K, Hu M, Draghici D, et al. A feedforward mechanism mediated by mechanosensitive ion channel PIEZO1 and tissue mechanics promotes glioma aggression. Neuron. 2018;100(4):799-+. doi:10.1016/j.neuron.2018.09.046.
  • Yu Y, Wu X, Liu S, Zhao H, Li B, Zhao H, Feng X. Piezo1 regulates migration and invasion of breast cancer cells via modulating cell mechanobiological properties. Acta Biochim Biophys Sin (Shanghai). 2021;53(1):10–18. doi:10.1093/abbs/gmaa112.
  • Girard CA, Lecacheur M, Ben Jouira R, Berestjuk I, Diazzi S, Prod’homme V, Mallavialle A, Larbret F, Gesson M, Schaub S, et al. A feed-forward mechanosignaling loop confers resistance to therapies targeting the MAPK pathway in BRAF-mutant melanoma. Cancer Res. 2020;80(10):1927–1941. doi:10.1158/0008-5472.CAN-19-2914.
  • Perotti V, Baldassari P, Molla A, Nicolini G, Bersani I, Grazia G, Benigni F, Maurichi A, Santinami M, Anichini A, et al. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells. Oncogene. 2019;38(22):4384–4396. doi:10.1038/s41388-019-0729-2.
  • Wicklein D, Otto B, Suling A, Elies E, Lüers G, Lange T, Feldhaus S, Maar H, Schröder-Schwarz J, Brunner G, et al. CEACAM1 promotes melanoma metastasis and is involved in the regulation of the EMT associated gene network in melanoma cells. Sci Rep. 2018;8(1):doi:10.1038/s41598-018-30338-4
  • Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52–67. doi:10.1016/j.cell.2010.03.015.
  • Galban S, Apfelbaum AA, Espinoza C, Heist K, Haley H, Bedi K, Ljungman M, Galbán CJ, Luker GD, Dort MV, et al. A bifunctional MAPK/PI3K antagonist for inhibition of tumor growth and metastasis. Mol Cancer Ther. 2017;16(11):2340–2350. doi:10.1158/1535-7163.MCT-17-0207.
  • Yue Y, Hui K, Wu S, Zhang M, Que T, Gu Y, Wang X, Wu K, Fan J, et al. MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma. Cell Death Dis. 2020;11(5):336. doi:10.1038/s41419-020-2518-9.
  • Yang R, Wang M, Zhang GH, Bao Y, Wu Y, Li X, Yang W, Cui H, et al. E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression. Br J Cancer. 2020;123(9):1445–1455. doi:10.1038/s41416-020-01032-y.
  • Polivka J Jr., Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 2014;142(2):164–175. doi:10.1016/j.pharmthera.2013.12.004.
  • Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.21387.
  • Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, Bray F. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385–400. doi:10.1002/ijc.27616.
  • Kai F, Laklai H, Weaver VM. Force matters: biomechanical regulation of cell invasion and migration in disease. Trends Cell Biol. 2016;26(7):486–497. doi:10.1016/j.tcb.2016.03.007.
  • Kim SE, Coste B, Chadha A, Cook B, Patapoutian A. The role of Drosophila Piezo in mechanical nociception. Nature. 2012;483(7388):209–212. doi:10.1038/nature10801.
  • Li CY, Rezania S, Kammerer S, Sokolowski, A, Devaney, T, Gorischek, A, Jahn, S, Hackl, H, Groschner, K, Windpassinger, C, et al. Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line. Sci Rep. 2015;5:8364.
  • Zhang J, Zhou Y, Huang T, Wu F, Liu L, Kwan JSH, Cheng ASL, Yu J, To KF, Kang W, et al. PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis. Mol Carcinog. 2018;57(9):1144–1155. doi:10.1002/mc.22831.
  • Han Y, Liu C, Zhang D, Men H, Huo L, Geng Q, Wang S, Gao Y, Zhang W, Zhang Y, et al. Mechanosensitive ion channel Piezo1 promotes prostate cancer development through the activation of the Akt/mTOR pathway and acceleration of cell cycle. Int J Oncol. 2019;55(3):629–644. doi:10.3892/ijo.2019.4839.
  • Lee Y-H, Lai C-W, Cheng Y-C. Fluid shear stress induces cell cycle arrest in human urinary bladder transitional cell carcinoma through bone morphogenetic protein receptor-Smad1/5 pathway. Cell Mol Bioeng. 2018;11(3):185–195. doi:10.1007/s12195-018-0523-1.
  • Ueasilamongkol P, Khamphaya T, Guerra MT, Rodrigues MA, Gomes DA, Kong Y, Wei W, Jain D, Trampert DC, Ananthanarayanan M, et al. Type 3 Inositol 1,4,5-Trisphosphate receptor is increased and enhances malignant properties in cholangiocarcinoma. Hepatology. 2020;71(2):583–599. doi:10.1002/hep.30839.
  • Cui C, Merritt R, Fu L, Pan Z. Targeting calcium signaling in cancer therapy. Acta Pharm Sin B. 2017;7(1):3–17. doi:10.1016/j.apsb.2016.11.001.
  • He F, Yu J, Yang J, Wang S, Zhuang A, Shi H, Gu X, Xu X, Chai P, Jia R, et al. m6A RNA hypermethylation-induced BACE2 boosts intracellular calcium release and accelerates tumorigenesis of ocular melanoma. Mol Ther. 2021;29(6):2121–2133. doi:10.1016/j.ymthe.2021.02.014.
  • Gudipaty SA, Lindblom J, Loftus PD, Redd MJ, Edes K, Davey CF, Krishnegowda V, Rosenblatt J. Mechanical stretch triggers rapid epithelial cell division through Piezo1. Nature. 2017;543(7643):118–121. doi:10.1038/nature21407.
  • Rode B, Shi J, Endesh N, Drinkhill MJ, Webster PJ, Lotteau SJ, Bailey MA, Yuldasheva NY, Ludlow MJ, Cubbon RM, et al. Piezo1 channels sense whole body physical activity to reset cardiovascular homeostasis and enhance performance. Nat Commun. 2017;8(1). doi:10.1038/s41467-017-00429-3.
  • Ranade SS, Qiu ZZ, Woo S-H, Hur SS, Murthy SE, Cahalan SM, Xu J, Mathur J, Bandell M, Coste B, et al. Piezo1, a mechanically activated ion channel, is required for vascular development in mice. Proc Natl Acad Sci U S A. 2014;111(28):10347–10352. doi:10.1073/pnas.1409233111.
  • Wang S-F, Chang Y-L, Tzeng Y-D, Wu C-L, Wang Y-Z, Tseng L-M, Chen S, Lee H-C. Mitochondrial stress adaptation promotes resistance to aromatase inhibitor in human breast cancer cells via ROS/calcium up-regulated amphiregulin–estrogen receptor loop signaling. Cancer Lett. 2021;523:82–99. doi:10.1016/j.canlet.2021.09.043.
  • Wang Z, Chen J, Babicheva A, Jain PP, Rodriguez M, Ayon RJ, Ravellette KS, Wu L, Balistrieri F, Tang H, et al. Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension. Am J Physiol Cell Physiol. 2021;321(6):C1010–C1027. doi:10.1152/ajpcell.00147.2021.
  • Retailleau K, Duprat F, Arhatte M, Ranade SS, Peyronnet R, Martins JR, Jodar M, Moro C, Offermanns S, Feng Y, et al. Piezo1 in smooth muscle cells is involved in hypertension-dependent arterial remodeling. Cell Rep. 2015;13(6):1161–1171. doi:10.1016/j.celrep.2015.09.072.
  • Pearlman RL, Montes de Oca MK, Pal HC, Afaq F. Potential therapeutic targets of epithelial–mesenchymal transition in melanoma. Cancer Lett. 2017;391:125–140. doi:10.1016/j.canlet.2017.01.029.
  • Huergo-Zapico L, Parodi M, Cantoni C, Lavarello C, Fernández-Martínez JL, Petretto A, DeAndrés-Galiana EJ, Balsamo M, López-Soto A, Pietra G, et al. NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines. Cancer Res. 2018;78(14):3913–3925. doi:10.1158/0008-5472.CAN-17-1891.
  • Loughrey MB, Fisher NC, McCooey AJ, Dunne PD. Comment on “Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes”. Br J Cancer. 2021;124(6):1175–1176. doi:10.1038/s41416-020-01213-9.
  • Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G. Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol. 2013;23(6):522–532. doi:10.1016/j.semcancer.2013.08.007.
  • Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, Hendrick E, Delage-Mourroux R, Mosser J, Borg C, et al. EMT is associated with an epigenetic signature of ECM remodeling genes. Cell Death Dis. 2019;10(3):205. doi:10.1038/s41419-019-1397-4.
  • Broders-Bondon F, Nguyen Ho-Bouldoires TH, Fernandez-Sanchez M-E, Farge E. Mechanotransduction in tumor progression: the dark side of the force. J Cell Biol. 2018;217(5):1571–1587. doi:10.1083/jcb.201701039.
  • Aksamitiene E, Kiyatkin A, Kholodenko BN. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Biochem Soc Trans. 2012;40(1):139–146. doi:10.1042/BST20110609.
  • Sabbah DA, Hajjo R, Bardaweel SK, Zhong HA. Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016-2020). Expert Opin Ther Pat2021;31(10):1–16.
  • Dey N, De P, Leyland-Jones B. PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials. Pharmacol Ther. 2017;175:91–106. doi:10.1016/j.pharmthera.2017.02.037.
  • Geuna E, Roda D, Rafii S, Jimenez B, Capelan M, Rihawi K, Montemurro F, Yap TA, Kaye SB, De Bono JS, et al. Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials. Br J Cancer. 2015;113(11):1541–1547. doi:10.1038/bjc.2015.373.
  • Wang SP, Cao S, Arhatte M, Li DH, Shi Y, Kurz S, Hu J, Wang L, Shao JC, Atzberger A, et al. Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice. Nat Commun. 2020;11:2303.